Mike Adams from NaturalNews.com, reporting for Infowars.com visits the Burzynski research institute and speaks with Dr. Stanislaw Burzynski, founder of the research institute and clinic. Dr. Burzynski talks about how his invention of gene-targeted cancer medications called Antineoplastons has shown much greater success rates for ridding the body of cancer than any conventional method. Dr. Burzynski also explains that while his invention should be applauded by the medical industry as a whole, it actually made him a target of scrutiny and many indictments.
A combination of the Whipple procedure and advances in drug therapy are advancing treatment of pancreatic cancer at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington Unviersity School of Medicine. For more information, visit siteman.wustl.edu.
Science & Reason on Facebook: tinyurl.com Spotlight on CERN – LHC News: A short tour of HIT – The Heidelberg Ion Beam Therapy Center. — Please subscribe to Science & Reason: • www.youtube.com • www.youtube.com • www.youtube.com — HIT: A new dimension in radiotherapy HIT is the world’s first heavy ion therapy facility with a movable radiation source (gantry). The beam head can be rotated by 360° around the patient. Numerous angles of irradiation can be selected. HIT is the world’s first ion therapy facility using the Intensity-controlled Rasterscan technique which offers the highest level precision in the three-dimensional radiation of tumors ever reached in the world. HIT is the first hospital-based treatment facility at a clinic in Europe where patients can be treated with protons as well as with various heavy ions (helium, carbon and oxygen ions). Ions offer the highest precision in tumor irradiation. Heavy ions also have a greater destructive power than the conventional radiation therapy. HIT ist the first therapy facility in the world that is equipped with robot-controlled treatment tables. This guaratees the highest level of precision in positioning the patient under the radiation source. • www.klinikum.uni-heidelberg.de — Heidelberg Ion Therapy Centre (HIT) A new cancer therapy facility developed at the GSI Centre for Heavy Ion Research has begun routine operations. Ion beam therapy is precise, effective and gentle. It offers better chances of a cure, shorter …
How to choose a primary treatment for prostate cancer. Men newly diagnosed with prostate cancer are generally told they have prostate cancer and given a long list of treatment options with little guidance. This video shares data gleaned from many men who have already faced a prostate cancer diagnosis and made a treatment choice. The lessons learned are shared with viewers.
How to choose a prostate cancer primary treatment choice. Newly diagnosed prostate cancer patients are frequently handed a long list of options to consider when they are told they have cancer but given little guidance. The information presented here reflects the expereinces of hundreds of men who have already chosen and undergone a treatment.